Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Lipidomic approach for stratification of acute myeloid leukemia patients
Its growing popularity stems from its profound impact on weight management and type 2 diabetes care
Evaluating Melatonin's Effects on Hepatocyte Lipidome: A Critique of Analytical Methods
Study Profile Efficacy and safety of HS-20094 in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 2 trial Format: Short Oral Discussion Presentation#: 732 Corresponding author: Department of Endocrinology, Peking University First Hospital, Beijing, China, Junqing Zhang First author: Department of Endocrinology, Peking University First Hospital, Beijing, China, Lin Liu Date: September 12, 2024,14:00 (CEST) Introduction and Objective HS-20094 is a novel dual GIP and GLP-1 receptor agonist
Jiang, Y., et al
impaired cholinergic transmission is the hallmark of Alzheimers disease [34, 35]
US$ 23.40
US$ 23.88
US$ 24.63
US$ 25.40
US$ 22.74
US$ 21.84
US$ 27.07
